Left ventricular chamber dimensions and wall thickness by cardiovascular magnetic resonance: comparison with transthoracic echocardiography.
暂无分享,去创建一个
Eckart Fleck | Eike Nagel | Bernhard Schnackenburg | Rolf Gebker | Reza Razavi | E. Fleck | E. Nagel | B. Schnackenburg | R. Gebker | S. Duckett | R. Razavi | V. Puntmann | J. Mirelis | Simon Duckett | Valentina O Puntmann | Jesus Mirelis | Michael Graefe | M. Graefe
[1] Warren J Manning,et al. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. , 2004, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[2] Eckart Fleck,et al. Usefulness of magnetic resonance imaging to distinguish hypertensive and hypertrophic cardiomyopathy. , 2010, The American journal of cardiology.
[3] E. J. Brown,et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.
[4] Jeroen J. Bax,et al. Real-time three dimensional echocardiography: current and future clinical applications , 2009, Heart.
[5] K. Dickstein,et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. , 2007, European heart journal.
[6] D. Faxon,et al. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echoca , 2003, Journal of the American College of Cardiology.
[7] William Stewart,et al. Recommendations for chamber quantification. , 2006, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.
[8] E. Fleck,et al. Magnetic Resonance Perfusion Measurements for the Noninvasive Detection of Coronary Artery Disease , 2003, Circulation.
[9] E. Fleck,et al. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography. , 1999, Circulation.
[10] D J Pennell,et al. Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance. , 2000, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[11] V L Morgan,et al. Normal human right and left ventricular mass, systolic function, and gender differences by cine magnetic resonance imaging. , 1999, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[12] A. Lalande,et al. MR imaging of the heart in patients after myocardial infarction: effect of increasing intersection gap on measurements of left ventricular volume, ejection fraction, and wall thickness. , 1999, Radiology.
[13] Udo Sechtem,et al. Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. , 2010, Journal of the American College of Cardiology.
[14] Eckart Fleck,et al. Improved accuracy of quantitative assessment of left ventricular volume and ejection fraction by geometric models with steady-state free precession. , 2002, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[15] R. Janz,et al. Estimation of regional stress in the left ventricular septum and free wall: an echocardiographic study suggesting a mechanism for asymmetric septal hypertrophy. , 1985, American heart journal.
[16] B. Maron,et al. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. , 2000, The New England journal of medicine.
[17] O. Simonetti,et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. , 2000, The New England journal of medicine.
[18] Stefan Neubauer,et al. Society for Cardiovascular Magnetic Resonance guidelines for reporting cardiovascular magnetic resonance examinations , 2009, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[19] D. Altman,et al. STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.
[20] E. Nagel,et al. EuroCMR (European Cardiovascular Magnetic Resonance) registry: results of the German pilot phase. , 2009, Journal of the American College of Cardiology.
[21] Eloisa Arbustini,et al. Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2007, European heart journal.
[22] A. Beckett,et al. AKUFO AND IBARAPA. , 1965, Lancet.
[23] E. Nagel,et al. Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols , 2008, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.